| Literature DB >> 35159506 |
Xiangwei Zhu1, Minglang Zhu1, Diheng He1, Xueyin Li1, Liu Shi2, Lan Wang2, Jianteng Xu3, Yi Zheng3, Tao Yin4.
Abstract
Carboxymethyl chitosan (CMCh) is an ampholytic chitosan derivative that manifests versatile applications in food industry, such as antibacterial ingredients and nutritional additives. However, its use as a cryoprotectant remains under-researched. In this study, the cryoprotective effect of CMCh oligosaccharide (CMCO) on frozen surimi (silver carp) was systematically investigated in terms of protein structures, gelling behaviors, and sensory qualities. CMCO (0.6%) was incorporated in the surimi before frozen storage (-18 °C for 60 days) while the commercial cryoprotectant (4% sucrose, 4% sorbitol) was used as a positive control. Results indicated that CMCO could inhibit the freezing-induced denaturation of myofibrillar protein, whose values of solubility, Ca2+-ATPase and sulfhydryl content were 24.8%, 64.7%, and 17.1% higher than the nonprotected sample, respectively, while the surface hydrophobicity was 21.6% lower. Accordingly, CMCO stabilized microstructure of the surimi gels associated with improved gel strength, viscoelasticity, water-holding capacities, and whiteness. Moreover, the cryoprotective effect of CMCO with higher degree of carboxymethyl substitution (DS: 1.2) was more pronounced than that of low-DS-CMCO (DS: 0.8). Frozen surimi treated with high-DS-CMCO achieved competitive gelling properties and sensory acceptability to those with the commercial counterpart. This study provided scientific insights into the development of ampholytic oligosaccharides as food cryoprotectants.Entities:
Keywords: carboxymethyl chitosan; denaturation; frozen surimi; gelling properties; myofibrillar protein
Year: 2022 PMID: 35159506 PMCID: PMC8833919 DOI: 10.3390/foods11030356
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Effects of CMCO on salt-soluble protein content (a) and Ca2+-ATPase activity (b) of MP at different storage time.
Figure 2Effects of CMCO on surface hydrophobicity (a) and sulfhydryl content (b) of MP at different storage time.
Figure 3Effects of CMCO on fluorescence intensity of MP at different storage time: (a) day 0, (b) day 15, (c) day 30, and (d) day 60.
Figure 4Microstructure of the gels prepared from frozen surimi with different cryoprotectants before and after storage for 60 days.
Figure 5Dynamic rheological properties of the gels prepared from frozen surimi before (a) and after (b) frozen storage, and (c) tan δ of surimi gel within the linear viscoelastic region. Values with different uppercase letters indicate statistically significant difference among samples with different cryoprotectants at the same storage time (p < 0.05). Values with different lowercase letters indicate significant difference among samples with the same cryoprotectants at different storage time (p < 0.05).
Figure 6Effects of CMCO on the mechanical strength (a) and water-holding capacity (b) of the gels prepared from frozen surimi at different storage time. Values with different uppercase letters indicate statistically significant difference among samples with different cryoprotectants at the same storage time (p < 0.05). Values with different lowercase letters indicate significant difference among samples with the same cryoprotectants at different storage time (p < 0.05).
Figure 7Schematic representation of the cryoprotective mechanism of CMCO for MP in frozen surimi.
Figure 8Effects of the CMCO on whiteness of the gels prepared from frozen surimi at different storage time.
Effect of CMCO on sensory attributes of the gels prepared from frozen surimi after 60 days of storage.
| Control | CMCO-A | CMCO-B | Commercial | |
|---|---|---|---|---|
| Taste | 3.78 ± 0.43 b | 4.18 ± 0.31 a | 4.34 ± 0.35 a | 4.22 ± 0.27 ab |
| Smell | 4.09 ± 0.45 a | 4.38 ± 0.35 a | 4.51 ± 0.38 a | 4.46 ± 0.40 a |
| Texture | 3.60 ± 0.25 b | 3.93 ± 0.34 ab | 4.17 ± 0.27 a | 4.20 ± 0.32 a |
| Juiciness | 3.52 ± 0.28 b | 4.38 ± 0.31 a | 4.51 ± 0.35 a | 4.46 ± 0.30 a |
| Color | 4.08 ± 0.24 a | 4.12 ± 0.22 a | 4.10 ± 0.25 a | 4.15 ± 0.33 a |
| Overall acceptability | 3.93 ± 0.35 b | 4.38 ± 0.27 ab | 4.67 ± 0.34 a | 4.49 ± 0.31 a |
Different letters indicate statistically significant differences among samples with different cryoprotectants (p < 0.05).